391 related articles for article (PubMed ID: 24928266)
1. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
3. Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study.
Dai J; Leone A; Mermel L; Hwang K; Pareek G; Schiff S; Golijanin D; Renzulli JF
Urology; 2015 Jan; 85(1):8-14. PubMed ID: 25458193
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
5. Clinical and microbiological determinants of infection after transrectal prostate biopsy.
Liss MA; Johnson JR; Porter SB; Johnston B; Clabots C; Gillis K; Nseyo U; Holden M; Sakamoto K; Fierer J
Clin Infect Dis; 2015 Apr; 60(7):979-87. PubMed ID: 25516194
[TBL] [Abstract][Full Text] [Related]
6. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
[TBL] [Abstract][Full Text] [Related]
7. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
[TBL] [Abstract][Full Text] [Related]
8. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR
Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581
[TBL] [Abstract][Full Text] [Related]
9. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
11. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL
Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305
[TBL] [Abstract][Full Text] [Related]
12. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
[TBL] [Abstract][Full Text] [Related]
13. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
14. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Fluoroquinolone Resistant Aerobic Organisms and Efficacy of Rectal Cleaning in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy.
Kongubol P; Santanirand P; Sirisreetreerux P; Viseshsindh W; Sangkum P
J Med Assoc Thai; 2016 Jun; 99(6):691-6. PubMed ID: 29901317
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
[TBL] [Abstract][Full Text] [Related]
18. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
[TBL] [Abstract][Full Text] [Related]
19. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
Cheung C; Patel HD; Landis P; Carter HB; Han M
Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
